Integral Health Asset Management, LLC Crispr Therapeutics Ag Transaction History
Integral Health Asset Management, LLC
- $987 Million
- Q2 2025
A detailed history of Integral Health Asset Management, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Integral Health Asset Management, LLC holds 100,000 shares of CRSP stock, worth $6.77 Million. This represents 0.49% of its overall portfolio holdings.
Number of Shares
100,000
Previous 150,000
33.33%
Holding current value
$6.77 Million
Previous $5.1 Million
4.7%
% of portfolio
0.49%
Previous 0.59%
Shares
9 transactions
Others Institutions Holding CRSP
# of Institutions
532Shares Held
68.7MCall Options Held
3.67MPut Options Held
2.25M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl10.2MShares$690 Million4.09% of portfolio
-
Capital International Investors Los Angeles, CA5.59MShares$379 Million0.05% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.68MShares$249 Million0.11% of portfolio
-
State Street Corp Boston, MA3.27MShares$222 Million0.01% of portfolio
-
Ubs Group Ag2.84MShares$193 Million0.02% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $5.28B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....